Diabetics exposed to telmisartan and enalapril - DETAIL

Description:

The goal of the trial was to compare the ACE inhibitor enalapril with the angiotensin-receptor blocker (ARB) telmisartan for noninferiority in renoprotection as assessed by the glomerular filtration rate (GFR) at five years in patients with type 2 diabetes, hypertension, and early nephropathy.